Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., and Ube Corp. have received FDA approval for their Omlonti 0.002 percent eye drops, which are designed to reduce elevated intraocular pressure in glaucoma patients.
Category: ROOT
Pfizer executive: Drugmakers should ‘rethink’ supply chain logistics
With COVID-19 vaccine-makers pivoting production as the virus mutates, Jim Cafone, Pfizer’s senior vice president of global supply chain, said it is time for pharmaceutical companies to redevelop their logistic strategies, The Wall Street Journal repor…
Past omicron infection outperforms 3 vaccine shots in study
Testing positive for omicron BA.1 plus two to three mRNA vaccines is the strongest protection against omicron BA.2 compared to being vaccinated with no past COVID-19 infections, a study published Sept. 21 in The Lancet Infectious Diseases found.
Meritus names vice president to lead talent management
Hagerstown, Md.-based Meritus Health has named Scott Salzetti vice president of team member services.
Medical equipment company VP pleads guilty to falsifying physician records in $50M fraud scheme
Kala Sloan, the vice president of two Raleigh, N.C.-based medical equipment companies, has pleaded guilty to falsifying physician orders to bill Medicare $50 million, according to a Justice Department report.
Healthcare consolidation hurts cancer patients, advocates tell The Lancet
Healthcare consolidation can drive up the cost of drugs and treatment for cancer patients, advocates told The Lancet.
How young physicians are paid by practice setting
Young physicians working in outpatient clinics are making on average $65,000 less than those in hospitals, according to Medscape’s “Young Physician Compensation Report 2022.”
7 hospitals seeking CEOs
Here are seven hospitals that recently posted job listings seeking CEOs.
10 hospitals seeking CFOs
Below are 10 hospitals and health systems that recently posted job listings seeking CFOs.
Physician group acquires $44.5M California medical office building
A medical office building in San Francisco was sold for $44.5 million, REBusiness reported Sept. 23.
